Navigation Links
Arterys Receives FDA Clearance For The First Zero-Footprint Medical Imaging Analytics Cloud Software With Deep Learning For Cardiac MRI
Date:1/10/2017

SAN FRANCISCO, Jan. 9, 2017 /PRNewswire/ -- Arterys, a pioneer in cloud-based medical imaging software, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Arterys Cardio DLTM application. Arterys Cardio DLTM is the first technology to be cleared by the FDA that leverages cloud computing and deep learning in a clinical setting. Arterys Cardio DLTM provides automated, editable ventricle segmentations based on conventional cardiac MRI images that are as accurate as segmentations performed manually by experienced physicians. The U.S. clearance complements the CE Mark received in late December for commercialization of the Arterys Cardio DLTM product in Europe.

"Arterys is committed to broadly accelerate the transformation of data-driven medicine through advanced cloud medical imaging analytics applications while always protecting patient data privacy," said Fabien Beckers, Arterys CEO. "Today's approval signifies a major regulatory milestone. This application demonstrates the power of deep learning combined with cloud supercomputation to aid physicians in interpreting medical images - eliminating tedious manual tasks carried out on a workstation by accurately automating those processes."

Continue Reading
Unlike traditional medical imaging software, Arterys Cardio DLTM uses deep learning, a form of artificial intelligence, to automate time-consuming analyses and tasks that are performed manually by clinicians today. The physician can edit the automated contours if desired. These images show the Cardio DLTM generated contours of the insides and outsides of the ventricles of the heart. The software can process a scan in just 10 seconds, compared to manual contouring performed by clinicians.
Unlike traditional medical imaging software, Arterys Cardio DLTM uses deep learning, a form of artificial intelligence, to automate time-consuming analyses and tasks that are performed manually by clinicians today. The physician can edit the automated contours if desired. These images show the Cardio DLTM generated contours of the insides and outsides of the ventricles of the heart. The software can process a scan in just 10 seconds, compared to manual contouring performed by clinicians.
Unlike traditional medical imaging software, Arterys Cardio DLTM uses deep learning, a form of artificial intelligence, to automate time-consuming analyses and tasks that are performed manually by clinicians today. The physician can edit the automated contours if desired. These images show the Cardio DLTM generated contours of the insides and outsides of the ventricles of the heart. The software can process a scan in just 10 seconds, compared to manual contouring performed by clinicians.

The Arterys Cardio DLTM application is vendor agnostic and was developed using data from several thousand cardiac cases. The software produces editable automated contours, providing precise and consistent ventricular function in seconds. The trained deep learning algorithm was validated as producing results within an expected error range comparable to that of an experienced clinical annotator. This clearance enables Arterys to make use of its unique clinical annotation platform, which collects ground-truth data every time a user views a study on Arterys.com. In the future, the deep learning model can be optimized as new data is collected from all global users.

Both the FDA clearance and CE Mark expands on the recently 510(k) cleared 4D Flow post-processing software features that provide comprehensive anatomy and blood flow visualization and quantification within and around the heart in a simple manner.

About Arterys, Inc.
Arterys, a pioneer in cloud-based medical imaging analytics software, is committed to accelerate the transformation of data driven medicine. The company's medical imaging analytics platform leverages the power of cloud computation and deep learning to support automated post-processing, diagnostic and therapeutic decisions. Starting with cardiac MRI, Arterys now plans to leverage its platform to create other imaging applications to make medical imaging services a whole more automated, quantitative, and useful.

Follow Arterys on Twitter at@ArterysInc
Contact: info@arterys.com

Media Contact:
Giana Gregga
Finn Partners
312-329-3910
giana.gregga@finnpartners.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/arterys-receives-fda-clearance-for-the-first-zero-footprint-medical-imaging-analytics-cloud-software-with-deep-learning-for-cardiac-mri-300387880.html


'/>"/>
SOURCE Arterys
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. Lyncean Technologies, Inc. receives $1.1M grant from DOE to develop the Compact Light Source
2. Regeneron Pharmaceuticals’ Industrial Operations & Product Supply Site Receives International Recognition for Operational Excellence
3. DiaCarta Inc. Receives CE Mark for QuantiVirus® HPV E6/E7 mRNA Assay
4. Physicians for Peace Receives Logo Embroidered Lab Coat Donation from Crooked Brook
5. APPLIED PHYSIOLOGY® Receives key US Patent Award for its Unique NAVIGATOR™ Technology
6. Iowa Educator Receives DuPont AgriSCIENCE Award for Teaching Excellence
7. Spinifex Receives $1.5m in R&D Tax Incentive for Research Activities Related to the Discovery of Treatments for Pain
8. Physicians for Peace Resource Mothers Program Receives Fleece Blanket Donation
9. Entia Receives Notices of Allowance for its Ergothioneine and Genetic Transporter Patents from the United States, Canada, and Israel
10. Physicians for Peace Receives Logo Embroidered Polo Shirt Donation
11. Suspect Detection Systems Receives Funding From Israel-Publicly Traded Biomedix Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2019)... ... ... At the most recent stem cell training course in Las Vegas ... Heroes Program. The Veterans included individuals and families from all over the US, with ... military Veteran, teacher or first responder to receive a regenerative therapy at a training ...
(Date:6/26/2019)... ... June 26, 2019 , ... Alice Branton today released research results ... properties of Magnesium Gluconate, which can prove to be beneficial for treating Hypomagnesemia. , ... differentiation peak, change in crystallite size , Over 142% increase in particle ...
(Date:6/11/2019)... ... 2019 , ... Thought Technology Ltd is pleased to announce ... Tech Ltd as its authorised distributor for the UK and Ireland. , ... and clinical assessment protocols to treat stress related disorders as well as provide ...
(Date:6/11/2019)... ... June 11, 2019 , ... Veterinary Regenerative Medicine ... (PSC) , has announced that their GMP facility for cell production is now ... manufacturing. This is an important milestone for VetStem as it expands into ...
Breaking Biology Technology:
(Date:8/6/2019)... , ... August 06, 2019 , ... ... and environmental concerns. One plant-based food in particular quickly entered the limelight – ... product developers use a thermogelling and emulsifying ingredient such as methyl cellulose. This ...
(Date:8/4/2019)... ... 2019 , ... Bioclinica, a leading provider of science and ... medical therapies, announced today that Michael O’Neal, M.D., Chief Medical Officer, Head of ... Inspiring People in the Life-Sciences Industry.” Dr. O’Neal was recognized for his ...
(Date:8/1/2019)... ... 01, 2019 , ... John R. Freeman, CPA, has joined BioLabs as Chief ... of BioLabs, which provides premier co-working spaces for life science startups in the most ... forecast and manage growth,” says Fruehauf. “BioLabs has expanded to 10 locations in just ...
Breaking Biology News(10 mins):